Fabry Disesase
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A proof-of Concept Study to Assess Safety and Tolerability of HM15421/GC1134A in Patients With Fabry Disease (NCT06858397) | GC Biopharma Corp | 2025-05-14 |
Track Fabry Disesase automatically
Every clearance here is in the API, with alerts when new ones post.